AstraZeneca (AZN) shifts U.S. listing from Nasdaq ADS to NYSE ordinary shares Feb 2, 2026—simplifying trading for global ...

AstraZeneca announces multibillion dollar investments in China as Big Pharma is increasingly looking east for innovation.

AstraZeneca shares launch on New York Stock Exchange - The UK based-pharmaceutical giant is transitioning to the market by delisting American Depositary Shares from the Nasdaq index.

By Andrew Silver SHANGHAI, Jan 30 (Reuters) - AstraZeneca will license experimental drugs for obesity and weight-related ...

By Andrew MacAskill and Maggie Fick BEIJING/LONDON, Jan 29 (Reuters) - UK drugmaker AstraZeneca will invest $15 billion in ...

The drug and vaccine maker is seeking to attract a broader investor base by leaning further toward the United States, where it generates almost half ...

The agreement to gain rights outside of China to a portfolio of experimental obesity and diabetes drugs could be valued at ...

Nine in 10 people worldwide have been infected with Epstein-Barr virus (EBV). | Nine in 10 people worldwide have been ...

AstraZeneca has outlined plans to invest $15 billion in China through 2030, making a broad commitment to the country to ...

British pharmaceutical group AstraZeneca said Thursday that it would invest $15 billion in China through 2030 to expand its ...

Add Yahoo as a preferred source to see more of our stories on Google. AstraZeneca could build a new six-storey block at ...

AstraZeneca said it entered into a collaboration agreement with China's CSPC Pharmaceuticals to gain rights to a portfolio of early-stage experimental obesity and diabetes drugs, in a deal potentially ...